Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand. Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021. Further, Company was converted from a private company to public company and
the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre.
The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. The core segments of operations of the Company in IVD Industry include Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids).
The Company established first manufacturing plant at Bawana, New Delhi in 2016-17. Further, during the year 2019, it incorporated POCT Science House Private Limited to engage in the business of running diagnostic laboratories. Since 2021, the facil ...ities have been subject to regular inspections and audits by regulators, including the CDSCO, State Drug Authority, Intertek, URS Certification Limited, and other European regulatory agencies, conducted on a periodic basis. As a part of growth strategy, Company incorporated subsidiary companies namely Q-Line Iris Private Limited which are engaged in the business of Radiology & Imaging Services, which was established in the year 2023. However, during the financial year 2025, Company has sold the controlling stake in Q-Line Nutraceuticals Private Limited to focus on the core business. The Company has acquired a manufacturing plant at Lucknow, Uttar Pradesh in 2025.
Company is planning a fresh issue IPO of 70,53,200 equity shares of Rs 10 each.
FAQs on Q-Line Biotech Ltd
1. Can I buy Q-Line Biotech Ltd from PL Capital? ›
Yes, you can invest in Q-Line Biotech Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Q-Line Biotech Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Q-Line Biotech Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Q-Line Biotech Ltd pay dividends? ›
Q-Line Biotech Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Q-Line Biotech Ltd ? ›
As of
11-Aug-2026 , 15:50:00 the share price for Q-Line Biotech Ltd. is ₹ 537.85 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Q-Line Biotech Ltd ? ›
The 52-week high and low of Q-Line Biotech Ltd share price is ₹ 431 - ₹ 600 as of
11-Aug-2026 , 15:50:00 .
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Q-Line Biotech Ltd
Invest systematically in stocks with the PL Capital app
